Skip to content
Shorla Oncology: A Leader in Innovative Oncology Solutions
  • About Us
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • Nelarabine Injection
  • Pipeline
    • SH-105
    • SH-110
    • SH-114
  • News
    • Company Updates
    • Media
  • Contact

Company Updates

Sharon and Orlaith featured in the Irish Times Top 50 people to watch in 2020

April 18th 2021January 4th 2020

Read More

SodEXo Women Mean Business (WMB) Female Newcomer Award 2019

April 15th 2021October 20th 2019

Read More

SH-111 Successful FDA pre-IND meeting

March 7th 2022October 7th 2019

Read More

Shorla Oncology featuring in Enterprise Ireland and the Local Enterprise Offices ‘Start’ campaign

March 7th 2022September 24th 2019

Read More

Ireland’s Best Young Entrepreneur 2019

March 7th 2022September 15th 2019

Read More

SH-105 Successful FDA pre-IND meeting

March 7th 2022June 14th 2019

Read More

American Society of Clinical Oncologists (ASCO) Annual Meeting 2019, Chicago, USA

March 7th 2022June 4th 2019

Read More

Network Ireland Tipperary Businesswoman of the year – Emerging New Business AWARD 2019

April 18th 2021May 24th 2019

Read More

Shorla attending MIT-Harvard Medical School Healthcare Innovation Bootcamp, Boston, USA

April 15th 2021May 7th 2019

Read More

Older posts
Newer posts
Page1 … Page5 Page6 Page7

IRELAND HQ:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

Shorla Pharma Ltd trading as Shorla Oncology®

 

US OFFICE:
245 Main St.,
2nd floor,
Cambridge,
MA 02142, USA

SITEMAP
PRIVACY POLICY
Company number: 618033
©SHORLA ONCOLOGY® 2022

© 2023 Shorla Oncology: A Leader in Innovative Oncology Solutions • Built with GeneratePress
  • About Us
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • Nelarabine Injection
  • Pipeline
    • SH-105
    • SH-110
    • SH-114
  • News
    • Company Updates
    • Media
  • Contact